Skip to main content

Medical Services

Medical Services
A longer duration of treatment with the injectable formulation of buprenorphine for opioid use disorder was associated with more favorable abstinence outcomes in a newly published study.
Coronavirus
Public health risk is forcing addiction treatment programs to rethink their typical approaches to patient drug testing at this time.
Medical Services
Nineteen projects to improve access to treatment have received funding in a Foundation for Opioid Response Efforts round that attracted nearly 450 proposals.
Medical Services
A major update to the American Society of Addiction Medicine's practice guideline for treating opioid use disorder includes the advice that unavailability or refusal of psychosocial treatment should not impede patient access to medication.
Medical Services
Overcoming stigma and cultivating a strong care team are among the components identified in Altarum's discussions with providers on addressing barriers to medication treatment for opioid use disorder.
Medical Services
An analysis of a state's publicly funded treatment for opioid use disorder found a substantially lower overdose death risk for patients receiving medication treatment, with risk for all patients increasing post-treatment.
Medical Services
A new initiative will seek to identify rapid-cycle improvements to treatment for patients with opioid use disorder and at risk of HIV.
Medical Services
Millennium Health data show widespread increases in positive drug test rates for the controversial substance kratom.
Medical Services
Researchers are testing a new formulation of a cocaine vaccine that could show promise for use in human populations.
Medical Services
A researcher advises that it is always prudent to react cautiously to reports about combinations of existing drugs that might be effective in treating stimulant dependence.
Medical Services
A speaker at this spring's Rx Drug Abuse & Heroin Summit discusses the latest national data on emerging drug threats, highlighting the need to focus on stimulant trends.
Back to Top